Venturi Wealth Management LLC Purchases 80 Shares of McKesson Co. (NYSE:MCK)

Venturi Wealth Management LLC raised its stake in shares of McKesson Co. (NYSE:MCK) by 3.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,632 shares of the company’s stock after acquiring an additional 80 shares during the period. Venturi Wealth Management LLC’s holdings in McKesson were worth $1,500,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. D.A. Davidson & CO. grew its holdings in McKesson by 5.1% during the 4th quarter. D.A. Davidson & CO. now owns 6,060 shares of the company’s stock valued at $3,454,000 after buying an additional 293 shares in the last quarter. Human Investing LLC bought a new stake in McKesson in the 4th quarter worth approximately $115,000. Principal Financial Group Inc. lifted its position in McKesson by 2.7% in the 4th quarter. Principal Financial Group Inc. now owns 284,648 shares of the company’s stock worth $162,224,000 after buying an additional 7,515 shares during the last quarter. Americana Partners LLC bought a new stake in McKesson in the fourth quarter valued at approximately $206,000. Finally, Capital Performance Advisors LLP lifted its position in McKesson by 1,155.2% in the fourth quarter. Capital Performance Advisors LLP now owns 364 shares of the company’s stock valued at $208,000 after purchasing an additional 335 shares during the last quarter. 85.07% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on MCK. Evercore ISI boosted their target price on McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a research note on Thursday, February 6th. Morgan Stanley boosted their target price on McKesson from $612.00 to $642.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. Citigroup dropped their target price on McKesson from $713.00 to $677.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Baird R W raised McKesson from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 7th. Finally, Wells Fargo & Company upped their price target on McKesson from $535.00 to $641.00 and gave the company an “equal weight” rating in a report on Friday, December 13th. Two research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and a consensus price target of $645.79.

Insider Activity

In related news, CEO Brian S. Tyler sold 8,961 shares of the company’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $600.66, for a total value of $5,382,514.26. Following the transaction, the chief executive officer now directly owns 69,625 shares of the company’s stock, valued at $41,820,952.50. This represents a 11.40 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Leann B. Smith sold 579 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total value of $331,645.41. Following the sale, the executive vice president now directly owns 864 shares in the company, valued at $494,890.56. This represents a 40.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 10,307 shares of company stock valued at $6,177,790. Corporate insiders own 0.11% of the company’s stock.

McKesson Stock Performance

Shares of MCK stock opened at $598.61 on Wednesday. McKesson Co. has a 52-week low of $464.42 and a 52-week high of $637.51. The firm has a market capitalization of $75.99 billion, a PE ratio of 27.41, a PEG ratio of 1.30 and a beta of 0.52. The stock has a fifty day simple moving average of $587.59 and a two-hundred day simple moving average of $561.91.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $8.03 earnings per share for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. On average, sell-side analysts forecast that McKesson Co. will post 32.69 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 3rd will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.47%. The ex-dividend date of this dividend is Monday, March 3rd. McKesson’s dividend payout ratio is presently 13.00%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.